Skip to main content

Table 1 General characteristics of study participants at each site and overall

From: Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study

Site, Country

N

Smoking status (%)

Sex male

Age (years)

BMI (kg/m2)

RS (%)

Comorbidities (%)

GNI

Current

Ex

Never

(%)

Mean ± SD 

Mean ± SD

 

CVD

Hypertension

Diabetes

High

Adana, Turkey

806

34.9

19.9

45.3

48.3

53.6 ± 10.4

29.6 ± 5.3

14.5

11.8

27.0

10.3

No

Annaba, Algeria

862

16.7

21.9

61.4

49.8

52.9 ± 9.7

28.3 ± 5.7

26.8

6.6

22.2

14.4

No

Bergen, Norway

656

26.2

36.6

37.2

49.2

59.7 ± 12.5

26.5 ± 4.3

9.3

15.4

29.4

5.9

Yes

Blantyre, Malawi

399

3.8

9.3

87.0

39.8

52.2 ± 9.7

25.1 ± 5.4

47.6

2.5

20.1

6.0

No

CapeTown, SouthAfrica

833

46.3

21.4

32.3

37.0

54.0 ± 10.2

27.9 ± 7.4

46.5

13.3

38.9

13.2

No

Chui, Kyrgyztan

858

19.8

9.7

70.5

31.5

53.0 ± 8.8

28.5 ± 5.6

12.5

16.6

29.7

5.7

No

Colombo, Srilanka

1020

12.9

7.5

79.6

44.6

53.7 ± 9.4

24.2 ± 4.6

81.3

5.9

20.6

13.4

No

Cotonou, Benin

677

1.8

0.1

98.1

43.9

51.5 ± 9.3

26.4 ± 5.5

78.4

5.3

29.8

2.5

No

Fes, Morocco

758

8.6

18.7

72.7

46.0

55.2 ± 10.0

27.9 ± 5.3

20.2

5.8

33.1

14.6

No

Guangzhou, China

471

29.9

14.0

56.1

49.9

54.0 ± 10.6

23.3 ± 3.3

30.1

9.8

17.6

4.0

No

Hannover, Germany

681

20.7

39.4

39.9

51.2

58.0 ± 10.9

27.3 ± 4.6

9.3

17.0

38.3

6.3

Yes

Ife, Nigeria

859

2.6

7.9

89.5

39.1

55.5 ± 11.5

25.4 ± 5.4

70.7

0.2

2.3

0.8

No

Krakow, Poland

522

29.3

32.4

38.3

50.8

55.6 ± 11.4

27.7 ± 4.7

10.2

32.4

42.0

11.1

Yes

Lexington, USA

505

26.5

33.9

39.6

40.4

56.5 ± 9.8

30.8 ± 6.8

26.5

29.3

49.1

17.4

Yes

Lisbon, Portugal

709

13.3

26.8

59.9

46.7

63.3 ± 11.3

28.2 ± 4.7

10.2

17.5

37.5

11.0

Yes

London, England

672

21.0

41.2

37.8

48.1

58.0 ± 11.4

27.1 ± 5.0

16.8

7.1

33.0

6.5

Yes

Maastricht, Netherlands

589

22.9

42.4

34.6

50.8

57.5 ± 10.6

27.4 ± 4.5

10.0

17.0

29.5

7.3

Yes

Manila, Philippines

890

32.7

20.2

47.1

42.2

52.2 ± 10.1

24.9 ± 4.7

64.2

11.0

26.5

6.0

No

Mumbai, India

440

6.6

3.2

90.2

62.5

51.1 ± 8.9

23.8 ± 4.0

69.8

2.3

10.0

5.2

No

NampicuanTalugtugPhilippines

722

35.9

16.8

47.4

49.3

54.1 ± 10.5

21.5 ± 3.9

58.3

8.3

19.7

2.6

No

Naryn, Kyrgyztan

816

15.1

9.8

75.1

38.5

53.2 ± 9.7

27.0 ± 5.0

9.8

11.6

15.7

1.0

No

Penang, Malaysia

646

20.3

5.0

74.8

50.9

54.8 ± 9.3

26.0 ± 4.5

58.2

2.8

25.2

14.4

No

Pune, India

843

8.9

3.0

88.1

59.4

52.4 ± 9.8

22.1 ± 3.8

66.3

1.4

5.1

2.1

No

Reykjavik, Iceland

755

18.4

42.5

39.1

53.1

56.3 ± 11.6

27.9 ± 4.9

12.7

15.4

32.1

4.8

Yes

Riyadh, Saudi Arabia

654

7.8

17.0

75.2

54.9

50.5 ± 7.5

31.2 ± 6.0

52.1

6.7

26.6

29.4

Yes

Salzburg, Austria

1255

19.3

33.5

47.2

54.3

57.6 ± 11.3

26.4 ± 4.2

9.3

12.5

28.9

6.4

Yes

Sousse, Tunisia

658

26.7

13.2

60.0

47.0

53.0 ± 9.0

29.3 ± 5.6

26.9

5.6

21.0

10.9

No

Srinagar, India

739

10.3

1.9

87.8

54.9

51.7 ± 10.3

22.4 ± 3.6

27.9

1.4

27.1

2.2

No

Sydney, Australia

423

14.9

36.6

48.5

49.6

58.5 ± 11.9

28.0 ± 5.1

12.5

12.8

29.8

8.5

Yes

Tartu, Estonia

611

18.2

29.3

52.5

50.2

60.8 ± 12.0

28.4 ± 5.2

8.8

37.3

40.1

7.2

Yes

Tirana, Albania

926

21.8

15.2

63.0

49.8

54.7 ± 10.6

28.1 ± 4.7

17.2

4.2

22.8

6.5

No

Uppsala, Sweden

547

14.3

43.1

42.6

51.7

58.4 ± 10.9

27.0 ± 4.4

10.1

11.0

28.7

3.8

Yes

Vancouver, Canada

821

13.9

38.4

47.7

41.7

55.8 ± 11.5

26.7 ± 5.2

8.5

12.8

20.2

7.1

Yes

Total

23,623

19.0

21.1

59.8

47.5

55.1 ± 10.8

26.7 ± 5.5

31.7

10.8

26.2

8.1

 
  1. BMI, body mass index; RS, Restricted spirometry; GNI, gross national income; CVD, cardiovascular disease; SD, standard deviation